Mechanical complications of ST segment elevation myocardial infarction: are they tangible?

ST segment elevation myocardial infarction (STEMI) is a life-threatening clinical condition which requires urgent medical attention (1). Recent technological advancement of drug eluting stents (DES) enabled STEMI patients with improved overall survival (2,3). However, despite these improvements, the mortality rate is relatively high even with bettered accessibility of coronary intervention which is currently available to patients all around the world (4). Many interventional cardiologists have wandered around the idea of reducing the mortality of STEMI patients. Even after successful primary coronary intervention (PCI) with complete revascularization of coronary arteries, patients still suffer from devastating consequences (5-7). Most common phenomenon regarding mortality after successful PCI is mechanical complication after revascularization. Mechanical complication comprises left ventricular free-wall rupture, ventricular septal defect (VSD), papillary muscle rupture, pseudo-aneurysm, true aneurysm, and post-myocardial infarction pericarditis (8-10). Throughout the years many researchers have investigated the prognosticators regarding STEMI.

Thrombolysis in myocardial infarction (TIMI) risk scoring system was devised to validate clinical parameters related to mortality (11). Myocardial infarct size and left ventricular ejection fraction was also in direct relation with mortality (12,13). However, causative investigation regarding mortality after successful PCI is relatively sparse with matters pertaining to mechanical complications.

Xu et al. (14) focused on cardiac rupture (CR) which was specified as free wall rupture, ventricular septal rupture, and papillary muscle rupture. They were able to collect more than 20,000 patients’ clinical data and divided them into two groups (CR group and control group). Their study was able to demonstrate that CR group, compared to control group, had longer total chest pain time, more prevalent refractory acute chest pain and lower left ventricular ejection fraction which obviously translates to larger infarct size [i.e., elevated creatine kinase (CK), CK-MB levels]. These findings are in concordance with previous and recent investigations regarding mechanical complications of STEMI (15,16). Furthermore, they were able to successfully isolate, via Cox regression model, electrocardiogram (ECG) depicting lateral infarction as a predisposing factor of CR.

Many studies stemming way back from the 1980s to as early as 2020s have contributed enormously to enhancing survival of STEMI patients. However, although the success rate of revascularization, whether it being PCI or CABG, have improved drastically throughout the years, the mortally rate due to catastrophic mechanical complication still lingers with unmitigated prevalence (17,18). It is definitely an area which needs further attention because if CR is predictable from index presentation at the emergency room (ER) then the attending cardiologist can utilize these clinical information while treating them.

This current study is commendable in many aspects. Firstly, the study result is clinically and logically coherent with current consensus (12,19,20). It is clear that clinical symptoms, infarction size is proportionate to incidences of CR. Secondly, identifying prognosticators of CR is a worthy result with significant clinical benefit. However, I do have some apprehensions when it comes to study design. The initial allocation of study population bares too big of a size discrepancy (196 vs. 21,820) and the study protocol does not draw attention to the average reader.

Mechanical complication is a poor prognosticator of STEMI. By extension, CR which is a severe form of mechanical complication, explicitly leads to increased cardiovascular mortality. If the identification is delayed, the patient will be in a catastrophic state. Therefore, it is crucial for physicians to be attentive whilst treating STEMI patients. Even after successful revascularization, the risk of CR remains. If the patients show clinical signs of CR, appropriate diagnostic measurements and treatment should be applied without delay. If concrete risk factors predicting these mechanical complications were to be identified, then physicians can have more clinical information for treatment options. That is why further studies regarding mechanical complications of STEMI is warranted for it will clearly help improve the survival of STEMI patients.

Acknowledgments

Funding: None.

Footnote

Provenance and Peer Review: This article was commissioned by the editorial office, Journal of Thoracic Disease. The article did not undergo external peer review.

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-22-705/coif). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

References

1. Hosseini SK, Soleimani A, Karimi AA, et al. Clinical features, management and in-hospital outcome of ST elevation myocardial infarction (STEMI) in young adults under 40 years of age. Monaldi Arch Chest Dis 2009;72:71-6. [PubMed]
2. Szummer K, Wallentin L, Lindhagen L, et al. Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014. Eur Heart J 2017;38:3056-65. [Crossref] [PubMed]
3. Lee MS, Pessegueiro A, Zimmer R, et al. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era. J Invasive Cardiol 2008;20:401-3. [PubMed]
4. Gershlick AH, Banning AP, Myat A, et al. Reperfusion therapy for STEMI: is there still a role for thrombolysis in the era of primary percutaneous coronary intervention? Lancet 2013;382:624-32. [Crossref] [PubMed]
5. Morrow DA, Antman EM, Snapinn SM, et al. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J 2002;23:223-9. [Crossref] [PubMed]
6. Choi SH, Yoon GS, Lee MJ, et al. Prognostic Impact of Plasma Glucose on Patients With Cardiogenic Shock With or Without Diabetes Mellitus from the SMART RESCUE Trial. Am J Cardiol 2022;175:145-51. [Crossref] [PubMed]
7. Choi SH, Jang HJ, Suh YJ, et al. Clinical Implication of Hypoxic Liver Injury for Predicting Hypoxic Hepatitis and In-Hospital Mortality in ST Elevation Myocardial Infarction Patients. Yonsei Med J 2021;62:877-84. [Crossref] [PubMed]
8. Mahtta D, Mohammed I, Elgendy IY. Overview of prevalence, trends, and outcomes of post myocardial infarction mechanical complications. Ann Cardiothorac Surg 2022;11:322-4. [Crossref] [PubMed]
9. Goraya MHN, Kalsoom S, Almas T, et al. Simultaneous Left Ventricular Aneurysm and Ventricular Septal Rupture Complicating Delayed STEMI Presentation: A Case-Based Review of Post-MI Mechanical Complications Amid the COVID-19 Pandemic. J Investig Med High Impact Case Rep 2021;9:23247096211031135. [Crossref] [PubMed]
10. Tripathi B, Aggarwal V, Abbott JD, et al. Mechanical Complications in ST-Elevation Myocardial Infarction (STEMI) Based on Different Reperfusion Strategies. Am J Cardiol 2021;156:79-84. [Crossref] [PubMed]
11. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000;102:2031-7. [Crossref] [PubMed]
12. Miller TD, Christian TF, Hopfenspirger MR, et al. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 1995;92:334-41. [Crossref] [PubMed]
13. Stolfo D, Cinquetti M, Merlo M, et al. ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis. Int J Cardiol 2016;215:340-5. [Crossref] [PubMed]
14. Xu Z, Li Y, Zhang R, et al. Risk factors for cardiac rupture after acute ST-segment elevation myocardial infarction during the percutaneous coronary intervention era: a retrospective case-control study. J Thorac Dis 2022;14:1256-66. [Crossref] [PubMed]
15. Gueret P, Khalife K, Jobic Y, et al. Echocardiographic assessment of the incidence of mechanical complications during the early phase of myocardial infarction in the reperfusion era: a French multicentre prospective registry. Arch Cardiovasc Dis 2008;101:41-7. [Crossref] [PubMed]
16. Crenshaw BS, Granger CB, Birnbaum Y, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000;101:27-32. [Crossref] [PubMed]
17. Elbadawi A, Elgendy IY, Mahmoud K, et al. Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute Myocardial Infarction. JACC Cardiovasc Interv 2019;12:1825-36. [Crossref] [PubMed]
18. Kitahara S, Fujino M, Honda S, et al. COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarction. Open Heart 2021;8:e001497. [Crossref] [PubMed]
19. Dai X, Kaul P, Smith SC Jr, et al. Predictors, treatment, and outcomes of STEMI occurring in hospitalized patients. Nat Rev Cardiol 2016;13:148-54. [Crossref] [PubMed]
20. Rollando D, Puggioni E, Robotti S, et al. Symptom onset-to-balloon time and mortality in the first seven years after STEMI treated with primary percutaneous coronary intervention. Heart 2012;98:1738-42. [Crossref] [PubMed]